Skip to main content
Equibles

Compagnie Lombard Odier SCmA

Position in NVCR — NovoCure Ltd

CIK 1615423 1204 GENEVA, V8
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$14,089
+$3,952 QoQ
Shares Held
930
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Compagnie Lombard Odier SCmA holds $65,227,557 across 10 Medical Devices names. NVCR ranks #8 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 432,818 $39,273,903
2 DXCM
Dexcom Inc
 194,121 $13,074,049
3 MDT
Medtronic plc
 109,230 $8,545,061
4 BSX
Boston Scientific Corp
 71,353 $3,045,346
5 GEHC
GE HealthCare Technologies Inc.
 17,020 $1,089,450
6 SYK
Stryker Corp
 424 $133,492
7 EW
Edwards Lifesciences Corp
 450 $40,707
8 NVCR
NovoCure Ltd
This page 		930 $14,089

All Filings in NVCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,089 930
2026-03-31 $10,137 930
2025-12-31 $50,814 3,930
2025-09-30 $50,775 3,930
2025-06-30 $69,954 3,930
2025-03-31 $70,032 3,930
2024-12-31 $117,114 3,930
2024-09-30 $61,425 3,930
2024-06-30 $67,320 3,930
2024-03-31 $61,425 3,930
2023-12-31 $58,674 3,930
2023-09-30 $63,469 3,930
2023-06-30 $163,095 3,930
2023-03-31 $236,350 3,930
2022-12-31 $225,918 3,080
2022-09-30 $234,018 3,080
2022-06-30 $214,060 3,080
2022-03-31 $255,178 3,080
2021-12-31 $231,246 3,080
2021-09-30 $353,156 3,040
2021-06-30 $674,332 3,040
2021-03-31 $401,827 3,040
2020-12-31 $519,120 3,000
2020-09-30 $333,930 3,000
2020-06-30 $177,900 3,000
2020-03-31 $202,020 3,000